403 related articles for article (PubMed ID: 21962523)
1. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
Zhang F; Wang XL; Shi J; Wang SF; Yin Y; Yang YS; Zhang WM; Zhu HL
Bioorg Med Chem; 2014 Jan; 22(1):468-77. PubMed ID: 24286761
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents.
Liu XH; Liu HF; Shen X; Song BA; Bhadury PS; Zhu HL; Liu JX; Qi XB
Bioorg Med Chem Lett; 2010 Jul; 20(14):4163-7. PubMed ID: 20538457
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL
Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.
Sun J; Li MH; Qian SS; Guo FJ; Dang XF; Wang XM; Xue YR; Zhu HL
Bioorg Med Chem Lett; 2013 May; 23(10):2876-9. PubMed ID: 23582273
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.
Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL
Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL
Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.
Zhang ZM; Zhang XW; Zhao ZZ; Yan R; Xu R; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3359-67. PubMed ID: 22520630
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.
Tang JF; Lv XH; Wang XL; Sun J; Zhang YB; Yang YS; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4226-36. PubMed ID: 22727369
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents.
Sun J; Yang YS; Li W; Zhang YB; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem Lett; 2011 Oct; 21(20):6116-21. PubMed ID: 21889345
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
